Sinovac Biotech annual debt-to-assets ratio
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Debt-to-Assets Ratio Growth & History (SVA)
Sinovac Biotech's debt-to-assets ratio was 0.06 for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.06 | 0.03 | +86.62% |
| 2024 | 2024-12-31 | 0.03 | 0.01 | +44.41% |
| 2023 | 2023-12-31 | 0.02 | 0.02 | +338.28% |
| 2022 | 2022-12-31 | 0.01 | −0.00 | −39.41% |
| 2021 | 2021-12-31 | 0.01 | −0.06 | −87.33% |
| 2020 | 2020-12-31 | 0.07 | 0.04 | +141.43% |
| 2019 | 2019-12-31 | 0.03 | 0.01 | +38.64% |
| 2018 | 2018-12-31 | 0.02 | −0.09 | −82.32% |
| 2017 | 2017-12-31 | 0.11 | −0.08 | −42.76% |
| 2016 | 2016-12-31 | 0.19 | 0.08 | +73.55% |
| 2015 | 2015-12-31 | 0.11 | −0.10 | −46.15% |
| 2014 | 2014-12-31 | 0.21 | 0.01 | +2.61% |
| 2013 | 2013-12-31 | 0.20 | 0.18 | +1160.06% |
| 2012 | 2012-12-31 | 0.02 | — | — |
Sinovac Biotech quarterly debt-to-assets ratio
Q4.12
Q4.13
Q4.14
Q4.15
Q4.16
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.06 | 0.03 | +86.62% |
| Q2 2025 | 2025-06-30 | 0.04 | — | — |
| Q4 2024 | 2024-12-31 | 0.03 | 0.01 | +44.41% |
| Q4 2023 | 2023-12-31 | 0.02 | 0.02 | +338.28% |
| Q4 2022 | 2022-12-31 | 0.01 | −0.00 | −39.41% |
| Q4 2021 | 2021-12-31 | 0.01 | −0.06 | −87.33% |
| Q4 2020 | 2020-12-31 | 0.07 | 0.04 | +141.43% |
| Q4 2019 | 2019-12-31 | 0.03 | 0.01 | +38.64% |
| Q4 2018 | 2018-12-31 | 0.02 | −0.09 | −82.32% |
| Q4 2017 · Dec 31 | 2017-12-31 | 0.11 | −0.08 | −42.76% |
| Q4 2016 | 2016-12-31 | 0.19 | 0.08 | +73.55% |
| Q4 2015 | 2015-12-31 | 0.11 | −0.10 | −46.15% |
| Q4 2014 | 2014-12-31 | 0.21 | 0.01 | +2.61% |
| Q4 2013 | 2013-12-31 | 0.20 | 0.18 | +1160.06% |
| Q4 2012 | 2012-12-31 | 0.02 | — | — |
Sinovac Biotech debt-to-assets ratio trends
Over the last five fiscal years, Sinovac Biotech's debt-to-assets ratio decreased from 0.07 to 0.06, a change of −0.01. The latest reported quarter, Q4 2025, shows 0.06.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗